BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 231 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,006,000 | +96.5% | 6,904 | +59.9% | 0.72% | +121.4% |
| Q1 2022 | $512,000 | -7.2% | 4,317 | +7.9% | 0.32% | -1.2% |
| Q4 2021 | $552,000 | -3.0% | 4,002 | -2.2% | 0.33% | -11.4% |
| Q3 2021 | $569,000 | -9.7% | 4,093 | -36.9% | 0.37% | -13.6% |
| Q2 2021 | $630,000 | +63.6% | 6,491 | +15.1% | 0.43% | +50.4% |
| Q1 2021 | $385,000 | -7.7% | 5,637 | +15.8% | 0.28% | -14.5% |
| Q4 2020 | $417,000 | +34.1% | 4,869 | +1.9% | 0.33% | +16.1% |
| Q3 2020 | $311,000 | -36.3% | 4,780 | -28.4% | 0.29% | -40.8% |
| Q2 2020 | $488,000 | +76.9% | 6,675 | -17.6% | 0.48% | +45.9% |
| Q1 2020 | $275,807 | – | 8,105 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |